A precisely defined cannabis-extract mouth spray moved from the most restricted drug schedule into the controlled-medicines schedule on 15 February 2017.[1] The government’s explanatory memorandum identified Sativex and the medicines route through which it could be supplied.[1] Wider rules for GHA-approved cannabis medicines followed in 2019.[2]
Listed for context. No score change is recorded for Gibraltar here.
References
- Drugs (Misuse) (Amendment) Regulations 2017, LN 25/2017Government of Gibraltar · 2017 · pp. 1–2; regulations 2–3 and explanatory memorandumarchived
- Drugs (Misuse) (Amendment) Regulations 20192019 · LN 205/2019, 16 October; definitions, regulations 10A and 12A, Schedules 2A–2Barchived
Checked. The date and the event were compared with a source that was read.